News - tasimelteon

Filter

Current filters:

tasimelteon

Popular Filters

Vanda's tasimelteon meets primary endpoint in Ph III study

18-12-2012

Shares of USA-based Vanda Pharmaceuticals (Nasdaq: VNDA) moved 2.8% higher to $3.22 in early trading…

NeurologicalPharmaceuticalResearchtasimelteonVanda Pharmaceuticals

Back to top